Affiliations 

  • 1 From the Department of Pathology and Medical Laboratory (F. Embong, Adzahar, Daud), Faculty of Medicine, Sultan Zainal Abidin University, from the Department of Pathology (W. Embong), Sultanah Nur Zahirah Hospital, from the Department of Pathology (Rameli), Dungun Hospital, Terengganu, from the Department of Pathology and Laboratory Medicine (Halim), College of Medicine, International Islamic University Malaysia, Pahang, and from the Department of Haematology (Zulkeflee, Bahar), School of Medical Sciences, University of Science Malaysia, Kelantan, Malaysia
Saudi Med J, 2025 Mar;46(3):292-298.
PMID: 40096988 DOI: 10.15537/smj.2025.46.3.20240771

Abstract

OBJECTIVES: To assess the prevalence of hemoglobin constant spring (Hb CS) in the Terengganu population, to evaluate the haematological parameters of individuals with heterozygous Hb CS, homozygous Hb CS, and compound heterozygous Hb CS, and to compare the effectiveness of high-performance liquid chromatography (HPLC) and capillary electrophoresis (CE) in detecting Hb CS.

METHODS: This study employed a cross-sectional design involving Form 4 secondary school students from Terengganu. Hemoglobin variants were analyzed using CE (CAPILLARYS2 Flex-Piercing System) and HPLC (VARIANT II). Molecular testing, including multiplex polymerase chain reaction (PCR) and amplification refractory mutation system-PCR techniques, was carried out to detect alpha thalassemia mutations.

RESULTS: The prevalence of Hb CS revealed 92.2% heterozygous (mean zone 2 CE peak value of 0.7%), 7.2% compound heterozygous (mean zone 2 CE peak value of 1.2%), and 0.5% homozygous cases (mean zone 2 CE peak value of 4.5%).

CONCLUSION: The study highlights a significant prevalence of Hb CS among the Terengganu population, with heterozygous cases being the most common. The peak values in zone 2 CE varied significantly among the heterozygous, compound heterozygous, and homozygous HbCS cases, indicating the potential utility of these measurements in distinguishing between different clinical phenotypes.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.